Issued Patents All Time
Showing 1–25 of 35 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12109266 | Modulating gabarap to modulate immunogenic cell death | Annamaria Gullà | 2024-10-08 |
| 12053468 | Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereof | Steven Norman Quayle, Simon Stewart Jones, Teru Hideshima | 2024-08-06 |
| 12005073 | Methods for modulating regulatory T cells, regulatory b cells, and immune responses using modulators of the april-taci interaction | Yu-Tzu Tai | 2024-06-11 |
| 11802132 | Small molecules for inducing selective protein degradation and uses thereof | Jun Qi, Lei Wu, Yan Song, Paul M. Park, Dharminder Chauhan | 2023-10-31 |
| 11702402 | Small molecules that block proteasome-associated ubiquitin receptor RPN13 function and uses thereof | Jun Qi, Lei Wu, Yan Song, Dharminder Chauhan | 2023-07-18 |
| 11517591 | Immunogenic peptides specific to BCMA and TACI antigens | Jooeun Bae, Nikhil C. Munshi | 2022-12-06 |
| 11497746 | Pharmaceutical combinations comprising a histone deacetylase inhibitor and a programmed death-ligand 1 (PD-L1) inhibitor and methods of use thereof | Steven Norman Quayle, Simon Stewart Jones, Teru Hideshima | 2022-11-15 |
| RE49240 | Inhibitors of histone deacetylase | Ralph Mazitschek, Teru Hideshima, Stephen J. Haggarty, Balaram Ghosh | 2022-10-11 |
| 11465983 | USP7 inhibitors for treating multiple myeloma | Sara Jean Buhrlage, Dharminder Chauhan, Sirano Dhe-Paganon, Xiaoxi Liu, Hyuk-Soo Seo | 2022-10-11 |
| 11447467 | Compounds for the degradation of STK4 and treatment of hematologic malignancies | Sara Jean Buhrlage, Teru Hideshima, Nathanael S. Gray, Xiaoxi Liu | 2022-09-20 |
| 11337975 | Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereof | Steven Norman Quayle, Simon Stewart Jones, Teru Hideshima | 2022-05-24 |
| 11083783 | XBP1, CD138, and CS1 peptides | Nikhil C. Munshi, Jooeun Bae | 2021-08-10 |
| 10710978 | STK4 inhibitors for treatment of hematologic malignancies | Nathanael S. Gray, Sara Jean Buhrlage, Francesca Cottini, Giovanni Tonon | 2020-07-14 |
| 10610517 | Compositions and methods for treating neoplastic diseases | Dharminder Chauhan, Michael Palladino | 2020-04-07 |
| 10302644 | Compositions and methods for treating multiple myeloma | Teru Hideshima, Francesca Cottini | 2019-05-28 |
| 10172905 | Treatment of protein degradation disorders | James E. Bradner, Edward Franklin Greenberg, Teru Hideshima, Nicholas Paul Kwiatkowski, Ralph Mazitschek +3 more | 2019-01-08 |
| 10017767 | Targets in multiple myeloma and other disorders | Giovanni Tonon, Francesca Cottini | 2018-07-10 |
| 9988343 | Inhibitors of histone deacetylase | Ralph Mazitschek, Teru Hideshima, Stephen J. Haggarty, Balaram Ghosh | 2018-06-05 |
| 9969679 | Anti-proliferative compounds and uses thereof | Teru Hideshima, Ralph Mazitschek, Gullu Gorgun | 2018-05-15 |
| 9950047 | XBP1, CD138, and CS1 peptides, pharmaceutical compositions that include the peptides, and methods of using such peptides and compositions | Jooeun Bae, Nikhil C. Munshi | 2018-04-24 |
| 9572854 | Treatment of protein degradation disorders | James E. Bradner, Edward Franklin Greenberg, Teru Hideshima, Nicholas Paul Kwiatkowski, Ralph Mazitschek +3 more | 2017-02-21 |
| 9446146 | Methods and agents for improving targeting of CD138 expressing tumor cells | Benjamin Daelken, Christoph Uherek, Teru Hideshima, Christoph Bruecher, Frank Osterroth +2 more | 2016-09-20 |
| 9309564 | Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer | Ronald A. DePinho, Ruben Carrasco, Giovanni Tonon, Cameron Brennan, John D. Shaughnessy +1 more | 2016-04-12 |
| 9248124 | Use of inhibitors of IκB kinase for the treatment of cancer | Julian Adams | 2016-02-02 |
| 9096681 | XBP1, CD138, and CS1 peptides | Nikhil C. Munshi, Jooeun Bae | 2015-08-04 |